1 Package leaflet: Information for the user Certican® 0.25 mg tablets
If you get any side effects talk to your doctor or pharmacist. This includes any possible side The active substance of Certican is everolimus.
pil.
Chemical Safety Practices Recommendations Everolimus (Afinitor
Everolimus (Afinitor Certican
CSPR Everolimus
Afinitor INN-everolimus
Due to between subject variability the recommended dose adjustments may not be optimal in all individuals therefore close monitoring of side effects is.
afinitor epar product information en
Votubia INN-everolimus
Due to between subject variability the recommended dose adjustments may not be optimal in all individuals therefore close monitoring of side effects is
votubia epar product information en
Afinitor (everolimus) Label
AFINITOR (everolimus) tablets for oral administration based on body surface area there were no adverse effects on delivery and lactation and.
s lbl
everolimus (indicated for rejection of transplanted organs) PSUSA
labelling of lymphoedema in the SmPC of Votubia but not Certican. Other side effects have occurred in a small number of people but their exact ...
en
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights
ADVERSE REACTIONS. 6.1. Clinical Trials Experience. 6.2. Postmarketing Experience. 7. DRUG INTERACTIONS. 7.1. Effect of Other Drugs on AFINITOR/AFINITOR
afinitor
Safety tolerability
https://aasldpubs.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/lt.20707
MEDICATION GUIDE ZORTRESS (ZOR-tres) (everolimus) Tablets
(everolimus) Tablets. What is the most important information I should know about ZORTRESS? ZORTRESS can cause serious side effects including:.
zortress pmg
AUSTRALIAN PRODUCT INFORMATION - CERTICAN®
Certican dispersible tablets 0.10mg; 0.25mg everolimus. development of rhabdomyolysis and other adverse effects associated with these agents. Angioedema.